Antacids Market Size to Grow by USD 712.45 Million | 41% of the market growth will originate from North America| Technavio

Antacids market will have AmerisourceBergen Corp., Bayer AG, and Cardinal Health Inc. as major participants

NEW YORK, June 24, 2022 /PRNewswire/ -- The latest market analysis report titled Antacids Market by Type and Geography - Forecast and Analysis 2022-2026 has been recently added to Technavio's catalog. The report also predicts the market to witness a potential growth difference of USD 712.45 million from 2021 to 2026. The antacids market will witness an accelerating growth momentum at a CAGR of 3.37% during the forecast period. The rising geriatric population is one of the key factors influencing the market growth. In addition, growing e-commerce market is one of the key antacids market trends that is expected to impact the industry positively in the forecast period. However, one of the key challenges to the global antacids market growth is the adverse effect of prolonged use of antacids.

View Market Report Sample to get YOY and growth variance analysis

Buy Report Now to Know more about the market scope and parent market analysis

Key Considerations for Market Forecast:

• Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
• Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
• Pre- as well as post-COVID-19 market estimates
• Quarterly impact analysis and updates on market estimates

Top 5 Vendor Analysis of Antacids Market 

The company offers various products including pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and relates equipment and services to various healthcare providers. The company offers antacids that is a naturally made water dissolving formula to cure acidity and heartburn, under the brand name of American Health Packaging.

The company offers antacids that help neutralize excess stomach acids, offering fast, effective relief from indigestion and heartburn, under the brand name of Rennie.

The company offers antacids that give relief of heartburn, sour stomach, acid indigestion and to alleviate or relieve the symptoms of gas, under the brand name of Cardinal Health.

The company offers antacids that can treate symptoms of heartburn and gastric discomfort, under the brand name of GSK.

The company offers products such as active pharmaceutical ingredients, drug delivery vehicles, hormone concentrates and over-the-counter medicines. The company offers antacids that deliver clinically proven heartburn relief, under the brand name of Humco.

Download Sample Report for additional product offerings from each contributing vendor

Antacids Market Segment Highlights

• Type
• Non-symmetric Antacids: The non-systemic antacids segment is expected to grow at a moderate rate in the coming years owing to better efficacy demonstrated when used in combination. In addition, the drugs used as combination therapies minimize the adverse effects and effectively treat GERD and acid reflux.
• Symmetric Antacids
• Geography
• North America: 41% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for antacids in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW. The high prevalence of GERD for which antacids are predominantly used, the increasing preference for OTC medications, and the practice of self-medication among the population will fuel the antacids market growth in North America over the forecast period. 
• Europe
• Asia
• Rest Of World (ROW)

Request Sample Report for more insights on each contributing segment

Reports that might interest you:

Genetic Testing Market by Product, Application, and Geography - Forecast and Analysis 2021-2025

Gene Panel Market by Product and Geography - Forecast and Analysis 2021-2025

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type

• 5.3 Non-symmetric antacids - Market size and forecast 2021-2026
• Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)

• 5.4 Symmetric antacids - Market size and forecast 2021-2026
• Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Type
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 Brazil - Market size and forecast 2021-2026
• Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification

• 10.3 AmerisourceBergen Corp.
• Exhibit 85: AmerisourceBergen Corp. - Overview
• Exhibit 86: AmerisourceBergen Corp. - Business segments
• Exhibit 87: AmerisourceBergen Corp. - Key offerings
• Exhibit 88: AmerisourceBergen Corp. - Segment focus

• 10.4 Bayer AG
• Exhibit 89: Bayer AG - Overview
• Exhibit 90: Bayer AG - Business segments
• Exhibit 91: Bayer AG - Key offerings
• Exhibit 92: Bayer AG - Segment focus

• 10.5 Cardinal Health Inc.
• Exhibit 93: Cardinal Health Inc. - Overview
• Exhibit 94: Cardinal Health Inc. - Business segments
• Exhibit 95: Cardinal Health Inc. - Key news
• Exhibit 96: Cardinal Health Inc. - Key offerings
• Exhibit 97: Cardinal Health Inc. - Segment focus

• 10.6 GlaxoSmithKline Plc
• Exhibit 98: GlaxoSmithKline Plc - Overview
• Exhibit 99: GlaxoSmithKline Plc - Business segments
• Exhibit 100: GlaxoSmithKline Plc - Key news
• Exhibit 101: GlaxoSmithKline Plc - Key offerings
• Exhibit 102: GlaxoSmithKline Plc - Segment focus

• 10.7 Humco Holding Group Inc.
• Exhibit 103: Humco Holding Group Inc. - Overview
• Exhibit 104: Humco Holding Group Inc. - Product / Service
• Exhibit 105: Humco Holding Group Inc. - Key offerings

• 10.8 Johnson and Johnson
• Exhibit 106: Johnson and Johnson - Overview
• Exhibit 107: Johnson and Johnson - Business segments
• Exhibit 108: Johnson and Johnson - Key news
• Exhibit 109: Johnson and Johnson - Key offerings
• Exhibit 110: Johnson and Johnson - Segment focus

• 10.9 Novartis AG
• Exhibit 111: Novartis AG - Overview
• Exhibit 112: Novartis AG - Business segments
• Exhibit 113: Novartis AG - Key offerings
• Exhibit 114: Novartis AG - Segment focus

• 10.10 Sanofi SA
• Exhibit 115: Sanofi SA - Overview
• Exhibit 116: Sanofi SA - Business segments
• Exhibit 117: Sanofi SA - Key news
• Exhibit 118: Sanofi SA - Key offerings
• Exhibit 119: Sanofi SA - Segment focus

• 10.11 Sun Pharmaceutical Industries Ltd.
• Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings

• 10.12 WellSpring Pharmaceutical Corp.
• Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
• Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
• Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources

• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio